Results 71 to 80 of about 2,975,622 (332)
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim +11 more
wiley +1 more source
Special Libraries, April 1953 [PDF]
Volume 44, Issue 4https://scholarworks.sjsu.edu/sla_sl_1953/1003/thumbnail ...
Special Libraries Association
core +4 more sources
Objective – This study assessed the needs for digital image delivery to faculty members in Fine Arts at York University in order to ensure that future decisions regarding the provision of digital images offered through commercial vendors and licensed by ...
Mary Kandiuk, Aaron Lupton
doaj +1 more source
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
Special Libraries, March 1937 [PDF]
Volume 28, Issue 3https://scholarworks.sjsu.edu/sla_sl_1937/1002/thumbnail ...
Special Libraries Association
core +2 more sources
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li +12 more
wiley +1 more source
Special Libraries, December 1947 [PDF]
Volume 38, Issue 10https://scholarworks.sjsu.edu/sla_sl_1947/1009/thumbnail ...
Special Libraries Association
core +3 more sources
Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Special Libraries, September 1933 [PDF]
Volume 24, Issue 8https://scholarworks.sjsu.edu/sla_sl_1933/1007/thumbnail ...
Special Libraries Association
core +2 more sources

